Clinical pathology

Professional nurse: clinical trials / 1 year FTC / CLS

A Professional Nurse – Clinical Trials position (one year contract) is available with our client, Clinical Laboratory Services (CLS) of the Wits Health Consortium in Braamfontein, Johannesburg – Gauteng. Background Clinical Laboratory Services (CLS) is a division of the Wits Health Consortium (WHC) of the School of Pathology. The main …

Read More »

Ferring and Rebiotix Present Flagship Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Compared to Placebo in Reducing Recurrence of C. difficile Infection

SAINT-PREX, Switzerland & ROSEVILLE, Minnesota – (BUSINESS WIRE) – Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented the results of the pivotal phase 3 PUNCH ™ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) compared to placebo. …

Read More »

California SB-642 Targets Hospitals and Management Service Organizations | Mintz – Perspectives on Healthcare

On May 3, 2021, the California Senate Health Committee approved SB-642 “Healthcare: Facilities: Medical Privileges”. The bill is currently pending in the California Senate. AB-705, which is substantially similar to SB-642, is also on hold at the California Assembly. If passed, the law will restrict the ability of hospital governing …

Read More »

Study confirms effectiveness of uveitis treatment

Reviewed by Bahram Bodaghi, MD, PhD The results of LOUVRE 2, a French post-marketing, prospective and observational study, confirm the real effectiveness of the intravitreal implant of dexamethasone 0.7 mg (Ozurdex, Allergan) for the treatment of non-infectious uveitis of the posterior segment relatively long-standing. The results also provide insight into …

Read More »

Voyager Therapeutics (VYGR) Announces Strategic Change and Leadership Transitions

Enter Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for serious neurological diseases, today announced key leadership transitions and a strategic shift towards a refocused pipeline and increased investment in its innovative, …

Read More »

Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers

Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers Data shownSLN124,an siRNA which targets TMPRSS6, Washingtonis onand effective in reducing plasma iron levelsand had a long duration of action Data ssupport oIn progress phase 1 sstudy of SLN124 in patients with thalassemia and myelodysplastic …

Read More »

AMP and APC urge Congress to pass VITAL law

The Association for Molecular Pathology (AMP) and the Association of Pathology Chairs (APC) congratulate U.S. Senator Rand Paul (R-KY) for introducing legislation that would allow molecular pathology professionals to continue to advance and improve offer high-quality laboratory-developed (LDP) test procedures for patient care. The Innovative Tests Verified in US Laboratories …

Read More »